CNBX Pharmaceuticals Release a New Corporate Presentation
- Tuesday, May 31, 2022, 8:22
- PR Newswire
- Add a comment
TEL AVIV, Israel and BETHESDA, MD, May 31, 2022 /PRNewswire/ — CNBX Pharmaceuticals Inc. (OTCQB: CNBXD), a global leader in the development of cancer related cannabinoid-based medicine, announced today the release of its updated corporate presentation, now available on the Company’s…
About the Author
admin has written 20736 stories on this site.